期刊文献+

1.5TMRI评估肺动脉高压患者右心功能及肺动脉血液动力学 被引量:14

The Assessment of Right Ventricular Function and Pulmonary Artery Hemodynamics in Patients with Pulmonary Hypertension by 1.5T MRI
下载PDF
导出
摘要 背景与目的肺动脉高压(pulmonary hypertension,PH)患者肺动脉压力增高,右心功能逐渐下降,最终导致右心衰竭而死亡,因而准确、无创地监测PH患者右心功能及肺动脉血液动力学改变尤为重要。本研究旨在评价心脏MRI(cardiac magnetic resonance imaging,CMRI)在评估PH患者右心功能及肺动脉血液动力学中的价值。方法对25例PH患者及30例健康志愿者进行心脏电影MRI(cine-MRI)及相位对比法MRI(PC-MRI)扫描。对cine-MRI扫描图像进行后处理,计算获得右心室舒张末期容积(end-diastolicvolume,EDV)、收缩末期容积(end-systolic volume,ESV)、搏出量(stroke volume,SV)、射血分数(ejection fraction,EF)及心肌质量(myocardial mass,MM),以上数据除EF外均经体表面积(body surfacearea,BSA)校正。对PC-MRI扫描图像进行处理并计算获得主肺动脉(main pulmonary artery,MPA)峰值流速及其顺应性。采用两独立样本t检验分析两组参数有无差异,明显性标准为P<0.05。结果与对照组相比,PH组右心室EDV、ESV及MM指数均明显高于后者(P<0.01),EF明显低于后者(P<0.01),SV指数与对照组无明显差异(P>0.05),MPA峰值流速及顺应性均明显低于对照组(P<0.01)。结论 CMRI在PH患者右心功能及MPA血液动力学参数评估中具有重要意义。 Background and objective Pulmonary hypertension (PH) is characterized by rising pulmonary arterial pressure, decreasing right ventricular (RV) function, and ultimately, RV failure.Therefore, it is important to monitor RV function and pulmonary artery hemodynamics accurately and noninvasively. This study evaluates cardiac magnetic resonance imaging (CMRI) in assessing RV function and pulmonary artery hemodynamics in patients with PH. Methods Cine-MRI and phase-contrast MRI (PC-MRI) were performed in 25 PH patients and 30 healthy volunteers. Cine-MRI images were postprocessed on Report Card software and the following parameters were obtained: RV end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), ejection fraction (EF), and myocardial mass (MM). Except for EF, all of the above parameters were normalized to body surface area (BSA). PC-MRI images were post-processed on Report Card software, peak velocity and distensibility of main pulmonary artery (MPA) could also be obtained. Student t test was employed for statistical assessment.Results Compared with controls, RV EDV, ESV and MM index in PH patients were significantly increased (P〈0.01), EF was significantly impaired (P〈0.01), peak velocity and distensibility of MPA were significantly lower (P〈0.01). SV index between the two groups had no significant difference (P〉0.05). Conclusion Cardiac MRI is of great value in the assessment of RV function and MPA hemodynamic parameters in patients with PH.
出处 《中国肺癌杂志》 CAS 北大核心 2012年第8期471-475,共5页 Chinese Journal of Lung Cancer
基金 天津市应用基础及前沿技术研究计划(No.10JCYBJC11000)资助~~
关键词 磁共振成像 高血压 肺性 心室功能 右肺动脉 血液动力学 Magnetic resonance imaging Hypertension, pulmonary Ventricular function Right pulmonary ar-tery Hemodynamics
  • 相关文献

参考文献17

  • 1Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J, 2009, 30(20): 2493-2537.
  • 2Weir EKME, Archer SL, Rubin LJ. Pulmonary hypertension. 2nd ed. Philadelphia, Pa: Churchill Livingstone, 2000: 1856-1884.
  • 3雷云霞,张晓,崔阳,董光富,罗日强.结缔组织病相关的肺动脉高压79例临床分析[J].中华医学杂志,2009,89(41):2934-2937. 被引量:6
  • 4Grothues F, Moon JC, Bellenger NG, et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J, 2004, 147(2): 218-223.
  • 5Tandri H, Daya SK, Nasir K, et al. Normal reference values for the adult right ventricle by magnetic resonance imaging. AmJ Cardiol, 2006, 98(12): 1660-1664.
  • 6Peacock AJ, Murphy NF, McMurrayJJV, et al. An epidemiological study of pulmonary arterial hypertension. Eur RespirJ, 2007, 30(1): 104-109.
  • 7Badesch BD, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol, 2009, 54(1 Suppl): S55-S66.
  • 8Hudsmith LE, Petersen SE, Francis JM, et al. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson, 2005, 7(5): 775-782.
  • 9Maceira AM, Prasad SK, Khan M, et al. Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Eur Heart J, 2006, 27(23): 2879-2888.
  • 10Sanz J, Dellegrottaglie S, Kariisa M, et al. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. AmJ Cardiol, 2007, 100(4): 731-735.

二级参考文献9

  • 1冷晓梅,田军伟,艾脉兴,曾小峰,唐福林.自身免疫性疾病并发肺动脉高压83例临床分析[J].中华风湿病学杂志,2006,10(2):97-100. 被引量:22
  • 2Task Force Members. Guidelines on diagnosis and treatment of pulmonary arterial hypertension the task force on diagnosis and treatment of pulmonary arterial hypertension of the european society of cardiology. European Heart J,2004,25:2243-2278.
  • 3British Cardiac Society Guidelines and Medical Practice Committee. Recommendations on the management of pulmonary hypertension in clinical practice. Heart,2001,86 Suppl 1:11-13.
  • 4Horn CA. Pulmonary hypertension and autoimmune disease. Chest, 1993, 104: 279-282.
  • 5Pan TL, Tlumboo J, Boey ML. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus, 2000, 9: 338-342.
  • 6Christman BW, Mcpherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl Med, 1992, 327: 70-75.
  • 7Varga J. Pulmonary hypertension in systemic sclerosis. Curr Opin Rheumatol, 2002, 14 : 666.
  • 8Nishimaki T, Aotsuka S, Kondo H, et al. Immunological analysis of pulmonary hypertension in connective tissue disease. J Rheumatol, 1999, 26: 2357-2362.
  • 9陈志营,毕黎琦,赵林阳.结缔组织病与肺动脉高压[J].中国实验诊断学,2003,7(6):551-555. 被引量:14

共引文献5

同被引文献130

  • 1彭新华,茅杰熙,范晔辉,吕传国,薛春华,顾庆春.小剂量测试技术在肺动脉CTA中对比剂注射优化方案的研究[J].现代医用影像学,2020,0(1):83-84. 被引量:7
  • 2张万军,张博,范国华.“双极低”联合全模型迭代重建技术在肺动脉CTA中的应用[J].临床放射学杂志,2021,40(3):465-469. 被引量:13
  • 3王丽华,张文普,姜卫香,钱玉娥.慢性阻塞性肺疾病肺动脉高压分支形态的影像学及流态功能改变[J].浙江大学学报(医学版),2010,39(6):594-601. 被引量:8
  • 4Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respira tory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J, 2009, 30(20) :2493-2537.
  • 5Pena E, Dennie C, Veinot J, et al. Pulmonary hypertension: How the radiologist can help. Radiographics, 2012, 32(1):9-32.
  • 6Chin KM, Kingman M, de Lemos JA, et al. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan treated patients with pulmonary arterial hypertension. Am J Cardiol, 2008,101(11) : 1669-1672.
  • 7Roeleveld RJ, Marcus JT, Faes TJ, et al. Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology, 2005,234(3):710-717.
  • 8Dellegrottaglie S, Sanz J, Poon M, et al. Pulmonary hypertension: Accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology, 2007, 243(1) :63-69.
  • 9Hudsmith LE, Petersen SE, Francis JM, et al. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson, 2005,7(5) :775-782.
  • 10Hoeper MM, Barbera JA, Channiek RN, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol, 2009,54(1 Suppl) : S85-S96.

引证文献14

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部